fintopic.
Docs Get the API

Eli Lilly's Q3 revenue and earnings

15 statements from 11 sources, Oct 28, 2026 12:14 UTC to Nov 2, 2026 18:53 UTC
News
Updated
Front page

Statements (10 of 15)

  1. Bullish

    Eli Lilly reported a third-quarter earnings beat driven by its GLP-1 portfolio.

    nasdaq.comHigh importance
  2. Bullish

    Eli Lilly reported a blowout quarter, indicating strong financial performance.

    fool.comHigh importance
  3. Bullish

    Eli Lilly reported a 39% increase in Q3 sales compared to the prior year.

    finance.yahoo.comHigh importance
  4. Bullish

    Eli Lilly reported third-quarter revenue of $24.4 billion, exceeding consensus estimates by $1.8 billion.

    deraktionaer.deHigh importance
  5. Bearish

    Eli Lilly's realized prices fell 15% as sales volume increased 53% year over year.

    fool.comHigh importance
  6. Bullish

    Eli Lilly's third-quarter net income increased 16% year over year.

    valor.globo.comHigh importance
  7. Bullish

    Eli Lilly reported third-quarter revenue growth and raised its sales guidance.

    deraktionaer.deHigh importance
  8. Bearish

    Eli Lilly's projected operating income is expected to decrease slightly.

    borsen.dk
  9. Bullish

    Eli Lilly's revenue for the third quarter of fiscal 2026 climbed 39% compared to the same period a year ago to reach $24.4 billion

    breakingthenews.netHigh importance
  10. Bearish

    Eli Lilly's earnings per share estimate collapsed by a third in just 30 days

    247wallst.comHigh importance

5 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=fbc21018-9cf5-48ab-a38e-48f01f631919 Get a free API key ↗